Mitchell Named “Young Innovator of Cellular and Molecular Bioengineering”
Mike Mitchell, PhD, J. Peter and Geri Skirkanich Assistant Professor of Innovation in Bioengineering (BE), was named a "Young Innovator of Cellular and Molecular Bioengineering."
New research from the Mitchell Lab offers a safer path for CAR T cell immunotherapy
The new method involves attaching a sugar molecule onto the surface of CAR T cells using metabolic labeling, a modification that enables the CAR T cells to attack cancer cells without any hindrance.
Carl June to receive the 2024 Breakthrough Prize in Life Sciences
June was awarded for the development of chimeric antigen receptor (CAR) T cell immunotherapy.
Penn is the one of the world’s best universities for VC-seeking entrepreneurs, per PitchBook data
PitchBook released its 2023 list of the best universities for founders, and Penn ranked fourth among undergraduate schools with 1,083 founders, 993 companies and $34 billion raised.
Mitchell Lab develops a microchip designed to transform the production of mRNA therapeutics and vaccines
“This technology has the potential to become a cornerstone in the field of nanomedicine, beyond RNA-based therapies,” Mitchell said in the Penn Today article.
Apellis Receives FDA Approval for SYFOVRE™ (pegcetacoplan injection) as the First Treatment for Geographic Atrophy (GA), a Leading Cause of Blindness
Penn spinout Apellis Pharmaceuticals, Inc. received U.S. Food and Drug Administration (FDA) approval for their drug SYFOVRE™ (pegcetacoplan injection).
Philly gene therapy companies tap into city’s workforce training program for lab techs
The Philadelphia Department of Commerce recently issued a $250,000 grant to the Community College of Philadelphia (CCP) for their cell and gene therapy industry lab technician certificate program.
Penn Spinout and I-Corps Graduate Neuroflow Named as 2023 Fire Awards honorees by PHL Inno
The Fire Awards are PHL Inno’s premiere awards program, showcasing the businesses, institutions and individuals driving the Philadelphia region’s innovation scene forward.
Penn Engineering’s Amy Gutmann Hall Reaches Construction Milestone
Once completed, the new facility, equipped with next-generation hybrid classrooms and laboratories, will support research in a variety of engineering sectors.
Penn Spinout ŌNŌCOR and B. Braun sign distribution agreement for ŌNŌ retrieval device
Onocor, a company formed through the UPstart program, has entered into an Amended and Restated License Agreement (ARLA) with Penn to expand its existing license to the ONO medical device.